tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Teva raises FY25 EPS view to $2.55-$2.65, up +5c at low end, consensus $2.56

Sees FY25 revenue $16.8B-$17B, lowering high-end of the range by -$200 million versus prior expectations, consensus $16.88B

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1